Abemaciclib
Eli Lilly 
['bcsm', 'breast']
at #asco22 we re presenting the trial design of postmonarch, an ongoing study in patients w/ metastatic hr+/her2- #breastcancer that have progressed or recurred following the use of a cdk4 &amp; 6i w/ endocrine therapy. view presentation details here: #bcsm 
US healthcare providers’ home for emerging science from Lilly Oncology and Loxo Oncology at Lilly. Please see our community guidelines: https://t.co/1q8vAe63mK